Literature DB >> 26722557

The investigation of foxe1 variations in papillary thyroid carcinoma.

Erkan Somuncu1, Adem Karatas2, Sina Ferahman2, Neslihan Saygili3, Eren Yilmaz3, Oguz Ozturk3, Metin Kapan2.   

Abstract

BACKGROUND: Recent reports indicated that incidence of thyroid carcinoma is increasing throughout the worldwide. The aim of our study was to determine a possible relationship between Forkhead box E1 (FOXE1) gene variants and histopathological features of papillary thyroid carcinoma.
METHODS: FOXE1 gene variations; rs894673, rs1867277 and rs3758249 were analyzed in 57 Papillary thyroid carcinoma patients and 51 age matched healthy control subjects. Restriction fragment length polymorphism (RFLP) technique was used to specifically detect the variations.
RESULTS: There was a significant difference in the distribution of rs894673 genotypes in Papillary thyroid carcinoma cases (P=0.01). AA genotype presence of rs1867277 was more significantly associated with several histopathological parameters such as focal and diffuse capsular invasion, lymphatic invasion, P3 with P4 tumor grade and surgical margins. AA genotype presence in rs1867277 variation was significantly associated with the classical variant which is subtype of papillary thyroid carcinoma. Furthermore, the presence of the allel A was found to be related with lymph node invasion risk by 2.46 fold, capsular invasion risk by 2.97 fold, and pT3 with pT4 pathological stage risk by 4.13 fold and the presence of allele A in rs1867277 was significantly associated with classic variants. The presence of allele A in rs1867277 was more significantly associated with several histopathological parameters in classic variant in papillary thyroid carcinoma cases such as, the presence of the A allele was found relationship with lymph node invasion risk by 2.0 fold, capsular invasion risk by 2.39 fold , and pT3 with pT4 pathological stage risk by 3.57 fold. In addition, AATT, AAAA and GATT haplotypes (rs1867277 and rs894673) were evaluated for association with papillary thyroid carcinoma cases. Our results indicate that the significant difference according to two-allele haplotype distribution between papillary thyroid carcinoma cases and control groups.
CONCLUSION: Our findings suggest that FOXE1 variations generate a higher risk for poor histopathological features of papillary thyroid carcinoma.

Entities:  

Keywords:  Thyroid; carcinoma; foxe1

Mesh:

Substances:

Year:  2015        PMID: 26722557      PMCID: PMC4680502     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

Review 1.  The emerging roles of forkhead box (Fox) proteins in cancer.

Authors:  Stephen S Myatt; Eric W-F Lam
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

Review 2.  Genetic predisposition to papillary thyroid cancer.

Authors:  Dorota Kula; Michał Kalemba; Beata Jurecka-Lubieniecka; Zbigniew Puch; Małgorzata Kowalska; Tomasz Tyszkiewicz; Monika Kowal; Daria Handkiewicz-Junak
Journal:  Endokrynol Pol       Date:  2010 Sep-Oct       Impact factor: 1.582

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility.

Authors:  Rute A Tomaz; Inês Sousa; Joana G Silva; Catarina Santos; Manuel R Teixeira; Valeriano Leite; Branca M Cavaco
Journal:  Clin Endocrinol (Oxf)       Date:  2012-12       Impact factor: 3.478

5.  A rare complication of colorectal surgery and its management: Chylous leakage.

Authors:  Arda Isik; Ismail Okan; Deniz Firat; Oguz Idiz
Journal:  Cir Esp       Date:  2014-08-07       Impact factor: 1.653

6.  Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry.

Authors:  Andrey Bychkov; Vladimir Saenko; Masahiro Nakashima; Norisato Mitsutake; Tatiana Rogounovitch; Alyaksandr Nikitski; Florence Orim; Shunichi Yamashita
Journal:  Thyroid       Date:  2013-06-21       Impact factor: 6.568

7.  Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.

Authors:  Giuseppe Mercante; Andrea Frasoldati; Corrado Pedroni; Debora Formisano; Luigi Renna; Simonetta Piana; Giorgio Gardini; Roberto Valcavi; Verter Barbieri
Journal:  Thyroid       Date:  2009-07       Impact factor: 6.568

8.  A new prognostic strategy for gastric carcinoma: albumin level and metastatic lymph node ratio.

Authors:  A Isik; I Okan; D Firat; B Yilmaz; A Akcakaya; M Sahin
Journal:  Minerva Chir       Date:  2014-06       Impact factor: 1.000

9.  Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.

Authors:  Julius Gudmundsson; Patrick Sulem; Daniel F Gudbjartsson; Jon G Jonasson; Asgeir Sigurdsson; Jon T Bergthorsson; Huiling He; Thorarinn Blondal; Frank Geller; Margret Jakobsdottir; Droplaug N Magnusdottir; Sigurborg Matthiasdottir; Simon N Stacey; Oskar B Skarphedinsson; Hafdis Helgadottir; Wei Li; Rebecca Nagy; Esperanza Aguillo; Eduardo Faure; Enrique Prats; Berta Saez; Mariano Martinez; Gudmundur I Eyjolfsson; Unnur S Bjornsdottir; Hilma Holm; Kristleifur Kristjansson; Michael L Frigge; Hoskuldur Kristvinsson; Jeffrey R Gulcher; Thorvaldur Jonsson; Thorunn Rafnar; Hannes Hjartarsson; Jose I Mayordomo; Albert de la Chapelle; Jon Hrafnkelsson; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2009-02-06       Impact factor: 38.330

10.  Importance of metastatic lymph node ratio in non-metastatic, lymph node-invaded colon cancer: a clinical trial.

Authors:  Arda Isik; Kemal Peker; Deniz Firat; Bahri Yilmaz; Ilyas Sayar; Oguz Idiz; Coskun Cakir; Ismail Demiryilmaz; Ismayil Yilmaz
Journal:  Med Sci Monit       Date:  2014-08-04
View more
  8 in total

1.  Serotonin transporter-linked polymorphic region genotypes in relation to stress conditions among patients with papillary thyroid carcinoma.

Authors:  Feng-Xia Chen; Xian-Shan Chen; Jun-Cheng Guo; Bao-Ai Zheng; Min Guo
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

2.  Genetic predisposition of SNPs in miRNA-149 (rs2292832) and FOXE1 (rs3758249) in thyroid Cancer.

Authors:  Rashida Khan; Humaira Shaheen; Qaisar Mansoor; Samina Asghar Abbasi; Shazia Fatima; Ayesha Ammar; Ruqia Mehmood Baig
Journal:  Mol Biol Rep       Date:  2021-10-13       Impact factor: 2.316

3.  FOXE1 Mutation Screening in a Case with Cleft Lip, Hypothyroidism, and Thyroid Carcinoma: A New Syndrome?

Authors:  Hugo Mendieta-Zerón; Angélica Jiménez-Rosales; Carlos Jhovani Pérez-Amado; Silvia Jiménez-Morales
Journal:  Case Rep Genet       Date:  2017-08-27

4.  A new panel of SNPs to assess thyroid carcinoma risk: a pilot study in a Brazilian admixture population.

Authors:  Isabelle C C Dos Santos; Julieta Genre; Diego Marques; Ananília M G da Silva; Jéssica C Dos Santos; Jéssica N G de Araújo; Victor H R Duarte; Angel Carracedo; Maria Torres-Español; Gisele Bastos; Carlos C de Oliveira Ramos; André D Luchessi; Vivian N Silbiger
Journal:  BMC Med Genet       Date:  2017-11-25       Impact factor: 2.103

5.  The Expression of FOXE-1 and STIP-1 in Papillary Thyroid Carcinoma and Their Relationship with Patient Prognosis.

Authors:  Enas M Fouad; Ola A Harb; Salem Reham Amin; Ola M El Farargy; Fady M Habib; Loay M Gertallah
Journal:  Iran J Pathol       Date:  2018-07-17

6.  Down-regulated HSDL2 expression suppresses cell proliferation and promotes apoptosis in papillary thyroid carcinoma.

Authors:  Jing Zeng; Xiao Ma; Jinjing Wang; Ran Liu; Yun Shao; Yanwei Hou; Zhiyuan Li; Yi Fang
Journal:  Biosci Rep       Date:  2019-06-04       Impact factor: 3.840

7.  Pseudogene legumain promotes thyroid carcinoma progression via the microRNA-495/autophagy pathway.

Authors:  Jie Sun; Yicheng Peng; Jianxia Liu; Hao Zhou; Liang Sun; Qin He; Enqiao Yu
Journal:  Oncol Lett       Date:  2021-06-24       Impact factor: 2.967

8.  Network-Based Analysis Reveals Association of FOXE1 Gene Polymorphisms in Thyroid Cancer Patients; A Case-Control Study in Southeast of Iran.

Authors:  Ahmad Mehrazin; Hossein Safarpour; Seyedeh Tahmineh Davoudi; Negin Parsamanesh; Farhad Saeedi; Ebrahim Miri-Moghaddam
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.